United Laboratories (HKG:3933) unit Zhuhai United Laboratories, Zhongshan Branch's Cefotaxime Sodium for Injection has been approved by China's National Medical Products Administration after it passed the regulator's consistency evaluation of quality and efficacy for generic drugs.
The drug is intended for the treatment of infections caused by susceptible bacteria, including lower respiratory tract, genitourinary tract, and gynecological infections among others, the pharmaceutical company said in a Tuesday filing with the Hong Kong bourse.